|
1
|
Lin YH, Jewell BE, Gingold J, Lu L, Zhao
R, Wang LL and Lee DF: Osteosarcoma: Molecular pathogenesis and
iPSC modeling. Trends Mol Med. 23:737–755. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang J, Liu S, Shi J, Li J, Wang S, Liu H,
Zhao S, Duan K, Pan X and Yi Z: The role of miRNA in the diagnosis,
prognosis, and treatment of osteosarcoma. Cancer Biother
Radiopharm. 34:605–613. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wan J and Zhang X, Liu T and Zhang X:
Strategies and developments of immunotherapies in osteosarcoma.
Oncol Lett. 11:511–520. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lindsey BA, Markel JE and Kleinerman ES:
Osteosarcoma overview. Rheumatol Ther. 4:25–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Geller DS and Gorlick R: Osteosarcoma: A
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.PubMed/NCBI
|
|
6
|
Xu S, Gong Y, Yin Y, Xing H and Zhang N:
The multiple function of long noncoding RNAs in osteosarcoma
progression, drug resistance and prognosis. Biomed Pharmacother.
127:1101412020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Z, Shen J, Chan MT and Wu WK: TUG1: A
pivotal oncogenic long non-coding RNA of human cancers. Cell
Prolif. 49:471–475. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li N, Shi K and Li W: TUSC7: A novel tumor
suppressor long non-coding RNA in human cancers. J Cell Physiol.
233:6401–6407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hung T and Chang HY: Long noncoding RNA in
genome regulation: Prospects and mechanisms. RNA Biol. 7:582–585.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang B, Su Y, Yang Q, Lv D, Zhang W, Tang
K, Wang H, Zhang R and Liu Y: Overexpression of long non-coding RNA
HOTAIR promotes tumor growth and metastasis in human osteosarcoma.
Mol Cells. 38:432–440. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pasic I, Shlien A, Durbin AD, Stavropoulos
DJ, Baskin B, Ray PN, Novokmet A and Malkin D: Recurrent focal
copy-number changes and loss of heterozygosity implicate two
noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31
in osteosarcoma. Cancer Res. 70:160–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cong M, Li J, Jing R and Li Z: Long
non-coding RNA tumor suppressor candidate 7 functions as a tumor
suppressor and inhibits proliferation in osteosarcoma. Tumour Biol.
37:9441–9450. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Liu Z, Yao B, Dou C, Xu M, Xue Y,
Ding L, Jia Y, Zhang H, Li Q, et al: Long non-coding RNA TUSC7 acts
a molecular sponge for miR-10a and suppresses EMT in hepatocellular
carcinoma. Tumour Biol. 37:11429–11441. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shang C, Guo Y, Hong Y and Xue YX: Long
non-coding RNA TUSC7, a target of miR-23b, plays tumor-suppressing
roles in human gliomas. Front Cell Neurosci. 10:2352016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren W, Chen S, Liu G, Wang X, Ye H and Xi
Y: TUSC7 acts as a tumor suppressor in colorectal cancer. Am J
Transl Res. 9:4026–4035. 2017.PubMed/NCBI
|
|
16
|
Wu X, Cai D, Zhang F, Li M and Wan Q: Long
noncoding RNA TUSC7 inhibits cell proliferation, migration and
invasion by regulating SOCS4 (SOCS5) expression through targeting
miR-616 in endometrial carcinoma. Life Sci. 231:1165492019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Siow MY, Ng LP, Vincent-Chong VK,
Jamaludin M, Abraham MT, Abdul Rahman ZA, Kallarakkal TG, Yang YH,
Cheong SC and Zain RB: Dysregulation of miR-31 and miR-375
expression is associated with clinical outcomes in oral carcinoma.
Oral Dis. 20:345–351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Luo D, Wilson JM, Harvel N, Liu J, Pei L,
Huang S, Hawthorn L and Shi H: A systematic evaluation of
miRNA:mRNA interactions involved in the migration and invasion of
breast cancer cells. J Transl Med. 11:572013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu X, Ajani JA, Gu J, Chang DW, Tan W,
Hildebrandt MA, Huang M, Wang KK and Hawk E: MicroRNA expression
signatures during malignant progression from Barrett's esophagus to
esophageal adenocarcinoma. Cancer Prev Res (Phila). 6:196–205.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Du F, Wu H, Zhou Z and Liu YU:
microRNA-375 inhibits osteogenic differentiation by targeting
runt-related transcription factor 2. Exp Ther Med. 10:207–212.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Wagner ER, Yan Z, Wang Z, Luther G,
Jiang W, Ye J, Wei Q, Wang J, Zhao L, et al: The calcium-binding
protein S100A6 accelerates human osteosarcoma growth by promoting
cell proliferation and inhibiting osteogenic differentiation. Cell
Physiol Biochem. 37:2375–2392. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang N, Ying MD, Wu YP, Zhou ZH, Ye ZM,
Li H and Lin DS: Hyperoside, a flavonoid compound, inhibits
proliferation and stimulates osteogenic differentiation of human
osteosarcoma cells. PLoS One. 9:e989732014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Prater S and Mckeon B: Cancer,
osteosarcoma. StatPearls [Internet] Treasure Island (FL):
StatPearls Publishing; 2020, https://www.ncbi.nlm.nih.gov/pubmed/31751058
|
|
26
|
Liu Y, Xing R, Zhang X, Dong W, Zhang J,
Yan Z, Li W, Cui J and Lu Y: miR-375 targets the p53 gene to
regulate cellular response to ionizing radiation and etoposide in
gastric cancer cells. DNA Repair (Amst). 12:741–750. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang Y, Yan W, He X, Zhang L, Li C, Huang
H, Nace G, Geller DA, Lin J and Tsung A: miR-375 inhibits autophagy
and reduces viability of hepatocellular carcinoma cells under
hypoxic conditions. Gastroenterology. 143:177–187 e8. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Song W, Xie J, Li J, Bao C and Xiao Y: The
emerging roles of long noncoding RNAs in bone homeostasis and their
potential application in bone-related diseases. DNA Cell Biol.
39:926–937. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
ENCODE Project Consortium, Birney E,
Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH,
Weng Z, Snyder M, Dermitzakis ET, et al: Identification and
analysis of functional elements in 1% of the human genome by the
ENCODE pilot project. Nature. 447:799–816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ling H, Vincent K, Pichler M, Fodde R,
Berindan-Neagoe I, Slack FJ and Calin GA: Junk DNA and the long
non-coding RNA twist in cancer genetics. Oncogene. 34:5003–5011.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang C, Shi H, Wang C, Wang J, Geng N,
Jiang X and Wang X: Correlation of microRNA-375 downregulation with
unfavorable clinical outcome of patients with glioma. Neurosci
Lett. 531:204–208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu Y, Deng Y, Yan X and Zhou T: Targeting
miR-375 in gastric cancer. Expert Opin Ther Targets. 15:961–972.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Elshafei A, Shaker O, Abd El-Motaal O and
Salman T: The expression profiling of serum miR-92a, miR-375, and
miR-760 in colorectal cancer: An Egyptian study. Tumour Biol.
39:10104283177057652017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cui F, Wang S, Lao I, Zhou C, Kong H,
Bayaxi N, Li J, Chen Q, Zhu T and Zhu H: miR-375 inhibits the
invasion and metastasis of colorectal cancer via targeting SP1 and
regulating EMT-associated genes. Oncol Rep. 36:487–493. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu L, Li M, Wang M, Yan D, Feng G and An
G: The expression of microRNA-375 in plasma and tissue is matched
in human colorectal cancer. BMC Cancer. 14:7142014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Arab K, Park YJ, Lindroth AM, Schäfer A,
Oakes C, Weichenhan D, Lukanova A, Lundin E, Risch A, Meister M, et
al: Long noncoding RNA TARID directs demethylation and activation
of the tumor suppressor TCF21 via GADD45A. Mol Cell. 55:604–614.
2014. View Article : Google Scholar : PubMed/NCBI
|
